SCLX Scilex Holding Company

0.5658USD-12.95%Mkt Cap: 3.98M USDP/E: —

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical syst…

Institutional holders20 on file

Key Statistics

Company
Market Cap3.98M USD
Enterprise Value107.81M USD
Revenue (TTM)31.61M USD
Gross Profit19.65M USD
Net Income (TTM)-358.73M USD
Revenue/Share3.64 USD
Last Price0.5658 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees34
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)0.78
PEG—
EV/EBITDA-0.39
EV/Revenue3.41
P/S0.13
P/B-0.01
EPS (TTM)-49.70 USD
EPS (Forward)0.73 USD
52W Range
0.50000% of range16.81
52W High16.81 USD
52W Low0.5000 USD
Profitability
Gross Margin64.97%
Oper. Margin-903.52%
EBITDA Margin0.00%
Profit Margin-1185.78%
ROE172.65%
ROA-98.29%
ROIC—
ROCE—
Growth
Revenue Growth-22.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.82M USD
CapEx (TTM)733.00K USD
FCF Margin-27.98%
FCF Yield-222.16%
Net Debt105.40M USD
Net Debt/EBITDA-0.38
Net Debt/FCF—
Balance Sheet
Debt/Equity-0.60
Current Ratio0.07
Quick Ratio0.05
Book Value/Sh-43.83 USD
Cash/Share0.08 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1606:1000
Split DateJun 16, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.7.03M
Float5.69M
Insiders11.67%
Institutions9.80%
Short Interest
Short Ratio2.8d
Short % Float2.38%
Short % Out.1.88%
Shares Short132.21K
Short (prev mo.)171.15K
Technical
SMA 503.131 (-81.9%)
SMA 2005.003 (-88.7%)
Beta1.93
S&P 52W Chg12.00%
Avg Vol (30d)70.80K
Avg Vol (10d)119.98K
Technical Indicators
RSI (14)8.4
MACD-0.6388
MACD Signal-0.6055
MACD Hist.-0.0334
BB Upper2.619 USD
BB Middle1.551 USD
BB Lower0.4831 USD
BB Width137.71%
ATR (14)0.2074 USD
Vol Ratio (20d)2.41x

About Scilex Holding Company (NASDAQ: SCLX)

›

Scilex Holding Company (NASDAQ: SCLX) is listed on Nasdaq, where its shares trade in USD. It belongs to the Drug Manufacturers - General industry, part of the Healthcare sector, and reports about 34 employees.

The shares were at 0.5658 USD on 20 November 2026, down 94.6% over 52 weeks. Its 52-week range is 0.5000 USD to 16.81 USD: the price is 96.6% below the high and 13.2% above the low.

Its market capitalisation is 3.98M USD.

Scilex Holding Company reports return on equity of 172.6% and revenue down 22.8% year over year.

Its debt exceeds its cash by 105.40M USD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.